-
Kestra Medical Technologies, Ltd. (KMTS) Misses Q1 EPS by 19c, raises guidance
-
Kestra Medical Technologies (KMTS) PT Raised to $30 at Stifel
-
Piper Sandler: 'We Strongly Encourage Investors to Buy the Stock'; Kestra Medical Technologies (KMTS) PT Raised
-
Kestra Medical Technologies, Ltd. (KMTS) Misses Q4 EPS by 7c
-
Kestra Medical Technologies (KMTS) files for 5.5M share offering
-
BTIG Starts Kestra Medical Technologies (KMTS) at Buy
-
Stifel Reiterates Buy Rating on Kestra Medical Technologies (KMTS)
-
Kestra Medical Technologies, Ltd. (KMTS) Reports Q3 Loss of $0.50, provides guidance
-
Piper Sandler on Kestra Medical Technologies (KMTS): 'Buy Any Weakness Tomorrow'
-
Stifel Reiterates Buy Rating on Kestra Medical Technologies (KMTS)
-
Kestra Medical Technologies, Ltd. (KMTS) Reports Q2 Loss of $2.21
-
Stifel Reiterates Buy Rating on Kestra Medical Technologies (KMTS)
-
Stifel Reiterates Buy Rating on Kestra Medical Technologies (KMTS)
-
Piper Sandler on Kestra Medical Technologies (KMTS): 'A Unique Duopoly Name to Own Here'
-
Wells Fargo Starts Kestra Medical Technologies (KMTS) at Overweight
-
Goldman Sachs Starts Kestra Medical Technologies (KMTS) at Neutral
-
Piper Sandler Starts Kestra Medical Technologies (KMTS) at Overweight
-
Stifel Starts Kestra Medical Technologies (KMTS) at Buy
-
Kestra Medical Technologies initiates trading at $22.95, after $17 IPO
-
Kestra Medical Technologies (KMTS) Prized Upsized 11.88M Share IPO at $17/sh
-
Kestra Medical Technologies (KMTS) shares indicate $27.20 after pricing IPO at $17

